| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.08. | Functional Brands: Gross Margin Jumps 710 Basis Points Despite Volatile Listing | 1 | pulse2.com | ||
| 17.08. | Functional Brands Inc. GAAP EPS of -$0.06, revenue of $1.87M | 1 | Seeking Alpha | ||
| 17.08. | Functional Brands Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.07. | NSE - Functional Brands Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| 01.07. | Functional Brands Inc. - 8-K, Current Report | - | SEC Filings | ||
| 15.06. | Functional Brands faces Nasdaq delisting after stock falls below $0.10 | 2 | Investing.com | ||
| 15.06. | Functional Brands Inc.: Functional Brands Inc. Receives Nasdaq Staff Delisting Determination | 429 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 15, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, announced today that on June... ► Artikel lesen | |
| 15.06. | Functional Brands Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| FUNCTIONAL BRANDS Aktie jetzt für 0€ handeln | |||||
| 05.06. | Functional Brands Inc.: Functional Brands Inc. Announces Active Interest from Multiple Strategic Partners to Fund BullionFX | Alchemy Commercialization Following Pending Acquisition of the BFX Assets | 792 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 5, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("MEHA" or the "Company") today announced advanced discussions with multiple strategic financial parties... ► Artikel lesen | |
| 04.06. | Functional Brands Inc.: Functional Brands Inc. Enters BullionFX | Alchemy Acquisition From a Position of Improving Financial Strength | 658 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 4, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a U.S.-domiciled Nasdaq issuer, which is party to a binding agreement to acquire the assets of BullionFX... ► Artikel lesen | |
| 03.06. | Functional Brands shareholders approve reverse stock split | 4 | Investing.com | ||
| 03.06. | Functional Brands Inc.: Functional Brands Inc. Clears Barrier to $142.9 Million BullionFX | Alchemy Acquisition | 551 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 3, 2026) - Functional Brands Inc. (NASDAQ: MEHA), announced that shareholders have voted to authorize the reverse stock split, removing an obstacle between... ► Artikel lesen | |
| 28.05. | Functional Brands Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 28.05. | Functional Brands Inc.: Functional Brands Announces Adjournment of Special Meeting of Stockholders | 586 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 27, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that the Company's Special... ► Artikel lesen | |
| 22.05. | Functional Brands Inc.: Functional Brands Enters into Agreement to Acquire Alchemy, a Gold-Backed Blockchain Settlement Platform, in a $142.9 Million Transaction | 810 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 22, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("Functional Brands" or the "Company") today announced the execution of a definitive agreement for the... ► Artikel lesen | |
| 18.05. | Functional Brands Inc.: Functional Brands Announces First Quarter 2026 Financial Results | 590 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 18, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced financial results for the... ► Artikel lesen | |
| 12.05. | Functional Brands Inc.: Functional Brands Inc. Announces Conversion Price Adjustment Agreement for Series C Preferred Stock | 376 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 12, 2026) - Functional Brands Inc. (NASDAQ: MEHA), (the "Company"), a leading innovator in wellness and performance products, today announced that it has... ► Artikel lesen | |
| 11.05. | Functional Brands Inc.: Functional Brands Inc. Signs Binding Letter of Intent for the Acquisition of the Assets of BullionFX | Alchemy for $142.9 million | 887 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 11, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, today announced it has executed... ► Artikel lesen | |
| 06.05. | Functional Brands Inc.: Functional Brands Inc. Announces Launch of GLP-Squared Injection | 439 | Newsfile | Lake Oswego, Portland--(Newsfile Corp. - May 6, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a pioneer in next-generation health and wellness solutions, today announced the official launch of... ► Artikel lesen | |
| 29.04. | Functional Brands Inc.: Tru2u.health Expands Digital Health Platform with the Addition of NAD+ - The Cellular Energy Molecule Transforming Modern Wellness | 342 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - April 29, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced a significant expansion... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 54,08 | -1,10 % | Bayer feiert FDA-Durchbruch mit 26 Prozent weniger Schlaganfällen - Mesoblast bereitet nächste Zelltherapie auf Milliardenmarkt vor | ||
| TEVA PHARMACEUTICAL INDUSTRIES | 38,550 | 0,00 % | Teva Announces R&D Leadership Transition As Chief Medical Officer Departs | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals Industries (TEVA) announced that Dr. Eric Hughes, Executive Vice President, Global R&D and Chief Medical Officer, will leave the company after accepting... ► Artikel lesen | |
| LB PHARMACEUTICALS | 40,040 | 0,00 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Announced accelerated timing of topline data readout from the pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia in the first half of 2027 Announced plans for pipeline expansion of LB-102 into... ► Artikel lesen | |
| MERCK KGAA | 146,90 | -1,01 % | Merck KGaA-Aktie: Halbleiter glänzen, US-Umsatz schmilzt | Merck KGaA hebt die Prognose an, als gäbe es dafür Treuepunkte - zum dritten Mal in diesem Jahr. Doch während die Chipsparte brummt, schmilzt der US-Umsatz in der Pharma-Sparte mit Mavenclad dahin.... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 61,24 | 0,00 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| NOVO NORDISK | 35,065 | -1,20 % | Novo-Nordisk-Aktie: -50% bei Wegovy - Preisschock oder Turnaround? | Bei Novo Nordisk steht eine wichtige Veränderung bevor. Ab Januar 2027 wird der dänische Pharmakonzern den amerikanischen Listenpreis seines Abnehmmedikaments Wegovy um rund -50% reduzieren. Auch Ozempic... ► Artikel lesen | |
| SANOFI | 85,08 | +1,69 % | Insmed-Aktie springt hoch: Kommt die Übernahme durch Sanofi? | Neue Übernahmespekulationen sorgen am heutigen Donnerstag für Bewegung im Pharmasektor: Der französische Sanofi-Konzern soll einem Medienbericht zufolge eine mögliche Übernahme des US-Biotechunternehmens... ► Artikel lesen | |
| ELI LILLY | 1.232,00 | +0,06 % | Dividendenbekanntmachungen (13.11.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCENTURE PLC IE00B4BNMY34 1,71 USD EUR ALBEMARLE CORPORATION PREF A US0126532003 0,9062 USD 0,8197 EUR AMERANT BANCORP INC US0235761014 0... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 3,705 | 0,00 % | Aquestive Therapeutics auf Jefferies-Konferenz: Anaphylm treibt das Wachstum voran | ||
| GENERATE BIOMEDICINES | 10,370 | 0,00 % | Generate Biomedicines auf der Jefferies Global Healthcare Conference: Pipeline-Fortschritte und Phase-III-Fokus | ||
| OMNIAB | 5,030 | 0,00 % | Veraxa Biotech AG: VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb | VXA-222 advances into next phase at VERAXAZURICH, SWITZERLAND, July 27, 2026 --
VERAXA Biotech AG (NASDAQ: VRXA; "VERAXA" or the "Company"), an emerging leader in designing novel cancer therapies... ► Artikel lesen | |
| KARDIGAN | 12,520 | 0,00 % | Kardigan, Inc.: Kardigan to Participate in the Jefferies Global Healthcare Conference | Kardigan, Inc. (Nasdaq: KARD), a precision cardiovascular company, today announced that the Company will participate in a fireside chat at the 2026 Jefferies London Healthcare Conference on Wednesday... ► Artikel lesen | |
| IAMBIC THERAPEUTICS | 14,290 | +0,21 % | Iambic Therapeutics, Inc. - 10-Q, Quarterly Report | ||
| DERMAPHARM | 33,150 | -0,90 % | Bafin beanstandet Konzernabschlus 2025 bei Dermapharm als fehlerhaft | FRANKFURT (dpa-AFX) - Der Konzernabschluss des Arzneimittelherstellers Dermapharm für das Jahr 2025 ist fehlerhaft. Zu diesem Schluss kommt die Finanzaufsicht Bafin nach einer im Sommer eingeleiteten... ► Artikel lesen | |
| SEAPORT THERAPEUTICS | 18,430 | 0,00 % | Seaport Therapeutics, Inc.: Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo at the 39th European College of Neuropsychopharmacology (ECNP) Congress | First scientific presentation of detailed PK data demonstrates dose-dependent increases in agomelatine exposure, no food effect, and no accumulation of exposure over seven days of dosing Detailed... ► Artikel lesen |